It’s 43 °C (104 °F) and Ulrik Uldall Nielsen has just travelled 70 kilometres to Thies from Senegal’s capital Dakar to visit one of the clinics expected to be enrolled in Novo Nordisk’s Changing Diabetes® in Children (CDiC) programme.
The opportunities to create positive change are all around us and stronger alignment of purpose is bringing us closer together. As a pharmaceutical company, we spend and invest significant resources every day on improving health for millions of people living with diabetes and other serious chronic diseases. But the cause of the diabetes epidemic, and the solutions required to make a change are multidimensional.
The Angola Sickle Cell Initiative, a public-private partnership of the Angola Ministry of Health, the Baylor College of Medicine International Pediatric AIDS Initiative (BIPAI), Texas Children’s Hospital and Chevron, is teaming up with the global biopharmaceutical company Bristol-Myers Squibb to provide children with sickle cell disease in Angola with an effective medication to which many patients in the country have lacked access.
Through its comprehensive diabetes management program in Colombia, Sanofi’s initiative with the Business Call to Action (BCtA) is addressing local barriers to diabetes care for people living at the base of the economic pyramid (BoP).
The Bristol-Myers Squibb Foundation has awarded a $5 million grant to Maine Medical Center (MMC) for the creation of a statewide initiative to improve the prevention, early detection and treatment of lung cancer in Maine, where incidence rates and deaths due to lung cancer are among the highest in the nation, according to the Centers for Disease Control and Prevention.
For the 3.5 million people infected with the hepatitis C virus in the United States, time is of the essence. Hepatitis C is the most common blood-borne infection in this country and, if not diagnosed and treated early enough, can cause liver damage, cirrhosis, liver cancer, and even death.
No child should ever die from a mosquito bite. Yet, today, in an era of extraordinary medical advancement, a child dies of mosquito-borne malaria every two minutes. Last year, this agonizing blood disease caused by the malaria parasite claimed nearly half a million lives—most of them children.
Still, there’s unprecedented cause for optimism. After 15 years of coordinated efforts to fight malaria, we’re seeing progress: Malaria deaths have declined 60 percent since 2000, meaning more than six million lives have been saved. During that same period, an analysis by the Roll Back Malaria initiative shows that 57 countries have reduced malaria cases by 75 percent or more.
My dad taught me a lot. Because of him, I’m a passionate sports fan. I was wrapped in a Cubs blanket when I was born – remnants of his hometown of Chicago traveled with him to my birthplace in Austin. Baseball, football, basketball, golf, soccer… he introduced me to all of those and more. But above all, he taught me to be competitive.
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...
Advanced security, fraud, and data protection, Keeping your accounts and information secure is a priority for us, and we know it’s a priority for you...
Cascale shares updates from its Board of Directors who serve as the principal governing body and are responsible for setting the strategic direction...
In the U.S. and around the world, Mary Kay remains steadfast in its commitment to ending the cycle of domestic violence and finding cures for cancers...
